KAYO MOTOR
834058
Zhejiang Zoenn Design
300901
Zhejiang Meorient Commerce & Exhibition Inc.
300795
Fujian Zitian Media Technology
300280
Zhejiang Prulde Electric Appliance
301353
CN Stock MarketDetailed Quotes
002513 Jiangsu Lanfeng Bio-chemical
- 6.07
- -0.15-2.41%
Market Closed Dec 13 15:00 CST
2.28BMarket Cap-5.97P/E (TTM)
6.29High6.02Low228.97KlotVolume6.17Open6.22Pre Close140.44MTurnover8.68%Turnover RatioLossP/E (Static)375.28MShares9.1752wk High-14.52P/B1.60BFloat Cap3.0252wk Low6.84Limit Up263.91MShs Float33.55Historical High5.60Limit Down4.34%Amplitude3.02Historical Low--Dividend TTM6.13Avg Price129.44KlotAsk--Div YieldTTM100Lot Size95.60KlotBid
Jiangsu Lanfeng Bio-chemical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 86.97%1.43B | 61.26%849.05M | -0.94%378.11M | 20.51%1.74B | -30.08%763.02M | -36.08%526.52M | -13.04%381.71M | 0.09%1.45B | 0.51%1.09B | 28.65%823.78M |
| Operating revenue | 86.97%1.43B | 61.26%849.05M | -0.94%378.11M | 20.51%1.74B | -30.08%763.02M | -36.08%526.52M | -13.04%381.71M | 0.09%1.45B | 0.51%1.09B | 28.65%823.78M |
| Other operating revenue | ---- | 5,706.25%20.69M | ---- | 2,349.86%39.33M | ---- | -60.77%356.34K | ---- | -71.25%1.61M | ---- | 63.12%908.44K |
| Total operating cost | 85.17%1.64B | 61.64%996.67M | 9.67%440.1M | 27.55%2B | -20.82%887.53M | -25.80%616.58M | -8.55%401.31M | -5.10%1.56B | -1.96%1.12B | 26.01%831M |
| Operating cost | 93.88%1.44B | 68.20%869.75M | 1.55%373.44M | 23.79%1.78B | -28.60%743.36M | -34.09%517.08M | -11.04%367.75M | -0.89%1.44B | 3.02%1.04B | 34.01%784.48M |
| Operating tax surcharges | 162.92%11.02M | 35.67%3.83M | -3.38%1.52M | 31.70%7.65M | -2.43%4.19M | -2.95%2.82M | 6.90%1.58M | -7.63%5.81M | -7.43%4.3M | -2.31%2.91M |
| Operating expense | 277.83%32.73M | 265.17%22.09M | 112.19%8.81M | 85.90%25.21M | 9.62%8.66M | 19.78%6.05M | 18.41%4.15M | 17.58%13.56M | -67.22%7.9M | -55.83%5.05M |
| Administration expense | -38.66%65.91M | -25.84%48.36M | -9.97%20.84M | 57.39%142.74M | 63.83%107.45M | 98.42%65.21M | 37.90%23.15M | -35.34%90.69M | -16.03%65.58M | -22.57%32.86M |
| Financial expense | 90.18%33.06M | -29.40%14.75M | 312.19%8.4M | 298.09%27.03M | 1,771.08%17.39M | 509.33%20.89M | -18.42%2.04M | -76.39%6.79M | -106.99%-1.04M | -66.15%3.43M |
| -Interest expense (Financial expense) | 67.91%33.05M | -3.68%18.96M | ---- | 95.76%26.53M | 381.90%19.68M | 581.82%19.68M | ---- | -40.02%13.55M | -66.01%4.08M | -40.12%2.89M |
| -Interest Income (Financial expense) | -13,180.52%-4.06M | -9,087.27%-2.81M | ---- | 86.97%-1.01M | 99.52%-30.59K | 97.10%-30.59K | ---- | -247.64%-7.76M | -252.18%-6.42M | -130.43%-1.06M |
| Research and development | 817.79%59.54M | 736.87%37.89M | 923.42%27.07M | 30.94%15.26M | 106.74%6.49M | 99.76%4.53M | 128.80%2.65M | -9.80%11.65M | -71.50%3.14M | -68.03%2.27M |
| Credit Impairment Loss | -543.53%-30.57M | -680.30%-29.34M | 77.26%-1.65M | 74.92%-12.94M | -170.10%-4.75M | -329.56%-3.76M | -4,099.97%-7.25M | -101.56%-51.62M | 349.48%6.78M | 36.98%-875.39K |
| Asset Impairment Loss | -216.01%-38M | -502.73%-29.52M | -102.20%-106.78K | -643.69%-118.87M | ---12.03M | ---4.9M | --4.86M | 94.74%-15.98M | ---- | ---- |
| Other net revenue | -663.70%-54.34M | -16,574.22%-52.65M | 2,004.62%5.35M | -51.65%-93.09M | -165.83%-7.12M | -118.05%-315.77K | -143.21%-281.08K | 81.25%-61.39M | 852.32%10.81M | 423.31%1.75M |
| Invest income | 13.50%428.55K | 64.47%621.01K | ---- | 1,268.89%31.62M | --377.58K | --377.58K | ---- | 29.25%2.31M | ---- | ---- |
| -Including: Investment income associates | 13.50%428.55K | -106.72%-25.37K | ---- | -53.26%1.08M | --377.58K | --377.58K | ---- | 29.25%2.31M | ---- | ---- |
| Asset deal income | -107.81%-358.33K | -104.98%-261.61K | ---- | -199.55%-1.46M | 458.43%4.59M | 161,371.86%5.25M | ---- | 176.52%1.47M | 3,798.24%821.55K | 95.37%-3.26K |
| Other revenue | 201.62%14.16M | 115.90%5.85M | 236.77%7.11M | 252.26%8.57M | 46.27%4.7M | 3.13%2.71M | 349.86%2.11M | 6.19%2.43M | 146.61%3.21M | 186.08%2.63M |
| Operating profit | -106.00%-271.16M | -121.60%-200.27M | -184.91%-56.63M | -92.10%-346.67M | -596.66%-131.63M | -1,551.74%-90.38M | -2,726.99%-19.88M | 66.07%-180.46M | 68.03%-18.89M | 72.22%-5.47M |
| Add:Non operating Income | -51.25%1.21M | -54.75%650.96K | -100.00%0.05 | -17.94%3.27M | -5.38%2.48M | -20.21%1.44M | 12.31%818.08K | 1.13%3.98M | -13.38%2.62M | 23.58%1.8M |
| Less:Non operating expense | 211.16%32.22M | 8,547.78%26.01M | -94.01%6.29K | -84.50%10.93M | 13,732.31%10.36M | 1,821.28%300.81K | 741.57%104.92K | 541.46%70.49M | -91.00%74.86K | -93.39%15.66K |
| Total profit | -116.60%-302.17M | -152.84%-225.63M | -195.54%-56.64M | -43.47%-354.33M | -753.24%-139.51M | -2,322.22%-89.24M | -1,401.41%-19.16M | 54.17%-246.97M | 71.27%-16.35M | 80.06%-3.68M |
| Less:Income tax cost | -1,525.36%-57.3M | -2,084.16%-48.12M | -225.55%-14.16M | -108.95%-6.6M | 17.14%-3.53M | 213.27%2.43M | -835.26%-4.35M | 254.66%73.72M | 71.01%-4.25M | 56.90%-2.14M |
| Net profit | -80.08%-244.87M | -93.66%-177.51M | -186.73%-42.48M | -8.43%-347.74M | -1,024.19%-135.98M | -5,840.74%-91.66M | -1,781.55%-14.81M | 34.71%-320.69M | 71.36%-12.1M | 88.58%-1.54M |
| Net profit from continuing operation | -80.08%-244.87M | -93.66%-177.51M | -186.73%-42.48M | -8.43%-347.74M | -1,024.19%-135.98M | -5,840.74%-91.66M | -1,781.55%-14.81M | 34.71%-320.69M | 71.36%-12.1M | 88.58%-1.54M |
| Less:Minority Profit | -872,499.46%-59.84M | -1,136,845.76%-38.14M | -13,540.12%-11.97M | -27,410,084.75%-15.48M | ---6.86K | ---3.35K | ---87.75K | ---56.46 | ---- | ---- |
| Net profit of parent company owners | -36.08%-185.03M | -52.05%-139.37M | -107.17%-30.51M | -3.61%-332.26M | -1,024.13%-135.97M | -5,840.52%-91.66M | -1,771.59%-14.73M | 34.71%-320.69M | 71.36%-12.1M | 88.58%-1.54M |
| Earning per share | ||||||||||
| Basic earning per share | -39.94%-0.5091 | -61.12%-0.3949 | -90.53%-0.0825 | -3.91%-0.8911 | -1,026.32%-0.3638 | -6,027.50%-0.2451 | -1,765.38%-0.0433 | 40.44%-0.8576 | 73.99%-0.0323 | 89.92%-0.004 |
| Diluted earning per share | -39.94%-0.5091 | -61.12%-0.3949 | -90.53%-0.0825 | -3.91%-0.8911 | -1,026.32%-0.3638 | -6,027.50%-0.2451 | -1,765.38%-0.0433 | 40.44%-0.8576 | 73.99%-0.0323 | 89.92%-0.004 |
| Other composite income | -56.80%120.11K | -56.80%120.11K | 49.35%272.43K | 278.03K | 278.03K | 153.81%182.41K | ||||
| Other composite income of parent company owners | -56.80%120.11K | -56.80%120.11K | ---- | 49.35%272.43K | --278.03K | --278.03K | ---- | 153.81%182.41K | ---- | ---- |
| Total composite income | -80.36%-244.75M | -94.11%-177.39M | -186.73%-42.48M | -8.41%-347.46M | -1,021.89%-135.7M | -5,822.72%-91.39M | -1,781.55%-14.81M | 34.79%-320.51M | 71.36%-12.1M | 88.58%-1.54M |
| Total composite income of parent company owners | -36.27%-184.91M | -52.38%-139.25M | -107.17%-30.51M | -3.58%-331.99M | -1,021.83%-135.7M | -5,822.50%-91.38M | -1,771.59%-14.73M | 34.79%-320.51M | 71.36%-12.1M | 88.58%-1.54M |
| Total composite income of minority owners | -872,499.46%-59.84M | -1,136,845.76%-38.14M | -13,540.12%-11.97M | -27,410,084.75%-15.48M | ---6.86K | ---3.35K | ---87.75K | ---56.46 | ---- | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Notarized Tianye Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Notarized Tianye Certified Public Accountants Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
